Similar articles for PMID: 23371303

Year	Number of Results
2006	1
2008	1
2011	5
2012	10
2013	15
2014	17
2015	14
2016	19
2017	21
2018	25
2019	13
2020	20
2021	43
2022	74
2023	20
2024	0

1

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

Zhanel GG, Lawson CD, Adam H, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Denisuik A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Drugs. 2013 Feb;73(2):159-77. doi: 10.1007/s40265-013-0013-7. Drugs. 2013. PMID: 23371303 Review.

2

Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.

Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, Lagacé-Wiens PRS, Walkty A, Denisuik A, Golden A, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Drugs. 2018 Jan;78(1):65-98. doi: 10.1007/s40265-017-0851-9. Drugs. 2018. PMID: 29230684 Review.

3

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.

Zhanel GG, Golden AR, Zelenitsky S, Wiebe K, Lawrence CK, Adam HJ, Idowu T, Domalaon R, Schweizer F, Zhanel MA, Lagacé-Wiens PRS, Walkty AJ, Noreddin A, Lynch Iii JP, Karlowsky JA. Zhanel GG, et al. Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.

4

Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.

Sharma R, Park TE, Moy S. Sharma R, et al. Clin Ther. 2016 Mar;38(3):431-44. doi: 10.1016/j.clinthera.2016.01.018. Epub 2016 Mar 2. Clin Ther. 2016. PMID: 26948862 Review.

5

Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections.

Lagacé-Wiens P, Walkty A, Karlowsky JA. Lagacé-Wiens P, et al. Core Evid. 2014 Jan 24;9:13-25. doi: 10.2147/CE.S40698. eCollection 2014. Core Evid. 2014. PMID: 24493994 Free PMC article. Review.

6

The β-Lactams Strike Back: Ceftazidime-Avibactam.

Zasowski EJ, Rybak JM, Rybak MJ. Zasowski EJ, et al. Pharmacotherapy. 2015 Aug;35(8):755-70. doi: 10.1002/phar.1622. Pharmacotherapy. 2015. PMID: 26289307 Free PMC article. Review.

7

Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.

Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F, Lagacé-Wiens PR, Rubinstein E, Gin AS, Walkty A, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Drugs. 2014 Jan;74(1):31-51. doi: 10.1007/s40265-013-0168-2. Drugs. 2014. PMID: 24352909 Review.

8

Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.

Sader HS, Castanheira M, Flamm RK, Farrell DJ, Jones RN. Sader HS, et al. Antimicrob Agents Chemother. 2014;58(3):1684-92. doi: 10.1128/AAC.02429-13. Epub 2013 Dec 30. Antimicrob Agents Chemother. 2014. PMID: 24379201 Free PMC article.

9

Ceftazidime/Avibactam: Who Says You Can't Teach an Old Drug New Tricks?

Barber KE, Ortwine JK, Akins RL. Barber KE, et al. J Pharm Pharm Sci. 2016 Oct-Dec;19(4):448-464. doi: 10.18433/J3X31R. J Pharm Pharm Sci. 2016. PMID: 28057163 Free article. Review.

10

Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections.

Shirley M. Shirley M. Drugs. 2018 Apr;78(6):675-692. doi: 10.1007/s40265-018-0902-x. Drugs. 2018. PMID: 29671219 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

271 results

Results by year